Topics

AstraZeneca & Novoheart to develop first ever human model for heart failure

06:10 EST 4 Dec 2019 | EPM Magazine

AstraZeneca has announced a collaboration with biotechnology company Novoheart to develop the world’s first functional model of a specific type of heart failure.

Original Article: AstraZeneca & Novoheart to develop first ever human model for heart failure

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca & Novoheart to develop first ever human model for heart failure"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...